References
- Hald J., Jacobsen E. Drug Sensitisinq the Organism to Ethyl Alcohol. Lancet 1948; 255: 1001–1004
- Knutsen B. Komplikasjoner ved Antabus-Behandling. Tidskr Norsk Laegefor 1949; 69: 436–437
- Kaaber K., Menne T., Tjell J. C., Veien N. Antabuse treatment of nickel dermatitis chelation - a new principle in the treatment of nickel dermatitis. Cont Derm 1979; 5: 221
- Poole R. L., Davis L. J. Hepatotoxicity secondary to Disulfiram. Drug Intel 1 Clin Pharm 1978; 12: 11
- Goyer P. F., Mayor L. F. Hepatotoxicity in Disulfiram treated patients. J Stud on Alcohol 1979; 40: 133–137
- Nassberger L. Disulfiram-induced hepatitis. Report of a case and review of the literature. Postgrad Med J 1984; 60: 71–73
- Eisen H. J., Ginsberg A. L. Disulfiram hepatotoxicity. Ann Intern Med 1975; 83: 673
- Norredam K. Chlorpromazine jaundice of long duration. Acta Med Scan 1963; 174: 163–167
- Ranek L., Buch Andreasen P. Disulfiram hepatotoxicity. Br Med J 1977; 2: 94–96
- Keffe E. B., Smith F. N. Disulfiram hypersensitivity hepatitis. JAMA 1974; 230: 435–436
- Guidelines for diagnosis of therapeutic drug-induced liver injury in liver biopsies. Review by an International Group, Lancet 1974; 1: 854–857
- Vazquez J. J., Pardo-Mindan J. Liver cell injury (bodies similiar to Lafora's) in alcoholics treated with disulfiram (Antabuse). Histopath 1979; 3: 377–384
- Morris S. J., Kanner R., Chiprut R. O., Schiff E. R. Disulfiram hepatitis. Gastroenterology 1978; 75: 100–102
- Snider G. B., Gogate S. A. Clinical observations following papaverine therapy. Ohio State Med J 1978; 74: 571–573
- Brodsky S. J., Culter S. S., Weiner D. A., Klein M. D. Hepatotoxicity due to treatment with Verapamil. Ann Int Med 1981; 94: 490–491
- Losek J. D., Werlin S. L. Sulfasalazine hepatotoxicity. Am J Pis Child 1981; 135: 1070–1071